Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Sagami prepares new anti-H. pylori agents

May 28, 1997

Hayashibara discovers human protein that induces IFN-gamma production

May 28, 1997

Novel antiinflammatory agent from Parke-Davis

May 27, 1997

Glaxo to submit NDA in Japan for lamivudine in hepatitis

May 27, 1997

Anti-H. pylori agents disclosed by Roussel Morishita

May 26, 1997

Novavax to initiate dose-ranging trial of Helicore

May 23, 1997

Salix reports promising clinical results for ulcerative colitis treatment

May 16, 1997

NIH announces prospective grant of licenses for IL-12 antibodies

May 16, 1997

Centocor reports results from Crohn's disease studies

May 14, 1997

Low-dose oral IFN-alpha + high-dose injectable IFN-alpha for hepatitis C

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...